Methods for inhibiting the growth of cancer cells expressing PSCA
US7527786B2 · kind B2 · utility
10Cited by
27References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 21, 2002 |
| Grant date | May 5, 2009 |
| Priority date | — |
| Expiry date | Aug 21, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.